FDA Grants Accelerated Approval to Zongertinib for HER2-Mutated NSCLC Dr. Kamal Kant Kohli11 Aug 2025 8:15 PM ISTThe FDA has granted accelerated approval to zongertinib (Hernexeos) for treating non-squamous non-small cell lung cancer patients with HER2 tyrosine...
Hearing Loss Risk Significantly Higher in People With Type 2 Diabetes, reveals research Dr Riya Dave11 Aug 2025 9:00 AM ISTResearchers have identified in a new study that type-2 diabetes mellitus (T2DM) patients are far more likely to develop hearing loss than the general...
Poor Sleep Patterns Linked to 65 Percent Higher Risk of Abdominal Aortic Calcification in Adults: Study Finds Medha Baranwal11 Aug 2025 8:45 AM ISTChina: A recent study published in Vascular Health and Risk Management has found that poor sleep habits may significantly increase the likelihood of...
UTEP study: Drinking coffee at night increases impulsive behavior Dr. Kamal Kant Kohli11 Aug 2025 8:15 AM ISTDo you find yourself reaching for a cup of coffee at night to stay alert? A new study from The University of Texas at El Paso suggests you might want...
Rare Blood Disorder Leads to Severe Kidney Damage in Untreated PNH: Case Report Medha Baranwal10 Aug 2025 9:45 PM ISTAustralia: A case report published in BMC Nephrology by Seethalakshmi Viswanathan and colleagues from the Tissue Pathology & Diagnostic Oncology,...
Red Cell Distribution Width-to-Albumin Ratio Shows Nonlinear Link With Retinopathy Risk: Study Dr Riya Dave10 Aug 2025 9:15 PM ISTResearchers have determined that the red cell distribution width-to-albumin ratio (RAR), a composite biomarker of systemic inflammation and...
FDA Approves Ajovy for Preventive Treatment of Episodic Migraine in Children Aged 6-17 Dr. Kamal Kant Kohli10 Aug 2025 9:00 PM ISTThe FDA has approved Ajovy (fremanezumab-vfrm) for preventive treatment of episodic migraine in pediatric patients aged 6 to 17 years who weigh at...
Guselkumab demonstrates superior efficacy in landmark clinical trials and offers new hope to Crohn's disease patients Dr. Kamal Kant Kohli10 Aug 2025 9:00 PM ISTIn a major advance for patients with Crohn's disease, a new study led by researchers at Mount Sinai Health System found that guselkumab, a medication...
Tumor diagnostics: AI model detects more than 170 types of cancer Dr. Kamal Kant Kohli10 Aug 2025 9:00 PM ISTThe MRI image shows a brain tumor in an inauspicious location,-and a brain biopsy will entail high risks for the patient, who had consulted us due to...
Long-Term Passive Smoking Doubles COPD Risk in Women, Study Finds Medha Baranwal10 Aug 2025 8:45 PM ISTChina: A new community-based study from Jinan, China, has revealed that women with long-term exposure to secondhand smoke face a significantly higher...
Orforglipron Shows Significant Weight Loss and Heart Health Benefits in Phase 3 Trial Dr. Kamal Kant Kohli9 Aug 2025 9:30 AM ISTIn the 72-week phase 3 ATTAIN-1 trial, the once-daily oral GLP-1 receptor agonist orforglipron led to substantial weight loss and improved...
Walking Faster and Farther Reduces CV Risk among People with High Blood Pressure: Study Dr. Kamal Kant Kohli9 Aug 2025 9:15 AM ISTAnalysis of over 36,000 people with high blood pressure has shown that taking more steps, even below the recommended daily target of 10,000 steps, and...
